Compare IMGN to:
After Hours: 8.15 N/A (N/A) 1:49pm ET
| Last Trade: | 8.15 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | |
| Prev Close: | 8.33 |
| Open: | 8.01 |
| Bid: | 7.58 x 500 |
| Ask: | N/A |
| 1y Target Est: | 11.80 |
| Day's Range: | 8.00 - 8.28 |
|---|---|
| 52wk Range: | 3.32 - 10.13 |
| Volume: | 244,054 |
| Avg Vol (3m): | 411,189 |
| Market Cap: | 465.04M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.66 |
| Div & Yield: | N/A (N/A) |
| Fri, Nov 27 | Biotech Stock Mailbag: Targaceptat TheStreet.com |
| Tue, Nov 24 | ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and ExpositionBusiness Wire |
| Thu, Nov 19 | UPDATE - ImmunoGen licenses anti-cancer technology to Amgenat Reuters |
| Thu, Nov 19 | ImmunoGen licenses technology to Amgen for $1MAP |
| Thu, Nov 19 | ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Company's TAP TechnologyBusiness Wire |
| Tue, Nov 17 | ImmunoGen, Inc. Announces Encouraging Clinical Data with Its IMGN901 Compound in the Treatment of Merkel Cell CarcinomaBusiness Wire |
| Tue, Nov 17 | Trading Overview for Poniard Pharmaceuticals Inc. Issued by Beacon EquityGlobeNewswire |
| Mon, Nov 16 | Cramer: Retail Investors Returning to Market?at CNBC |
| Thu, Nov 12 | You Missed the Best Day to Buyat Motley Fool |
| Wed, Nov 11 | ImmunoGen Chairman Mitchel Sayare steps downAP |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.